Skip to main menu Skip to main content Skip to footer

Clinical Trials

The Retina Associates of Kentucky is an active participant in national research trials. The tireless efforts of our patients and staff have led to the approval of many treatments now considered to be standard of care. Our continuing efforts and involvement in clinical research will lead to superior treatments to ultimately preserve sight.

Please call (859)-263-3900 extension 145 for more information and participation criteria in our active clinical trials.

Current Studies at Retina Associates of Kentucky

Eyepoint

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects with Wet AMD

Annexon

A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham-Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 Administered by Intravitreal Injection in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) – ARCHER II

4D Molecular Therapeutics

A Phase 3 Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-1)